Cite

HARVARD Citation

    Vendrely, V. et al. (n.d.). PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers. Radiotherapy and oncology. pp. S367-S368. [Online]. 
  
Back to record